Expressions of programmed death-ligand 1 (PD-L1) and its receptor, programmed cell death-1 (PD-1), are observed across a variety of cell types, like tumor cells (TCs) or antigen-presenting cells, T cells, reducing the activation of immune cells (ICs) [121]. The gene discussed is PDCD1; the disease is neoplasm.